ALNY

Alnylam Pharmaceuticals, Inc. News Headlines

$57.94
*  
0.09
0.16%
Get ALNY Alerts
*Delayed - data as of Jul. 11, 2014 10:44 ET  -  Find a broker to begin trading ALNY now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    ALNY Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Sector Update: Healthcare
11/7/2013 4:56:11 PM - MT Newswires

Wider-than-Expected Q3 Loss at Alnylam - Analyst Blog
11/7/2013 11:00:01 AM - Zacks.com

3 Potential Game Changers In The Biotech Industry
11/5/2013 4:45:00 PM - Seeking Alpha

Pipeline Progress at Alnylam - Analyst Blog
10/30/2013 5:33:30 PM - Zacks.com

Pipeline Progress at Alnylam - Analyst Blog
10/14/2013 3:46:10 PM - Zacks.com

Rxi Pharmaceuticals Is Undervalued In The RNAi Sector
10/14/2013 9:53:00 AM - Seeking Alpha

Pipeline Update at Alnylam - Analyst Blog
10/8/2013 5:27:32 PM - Zacks.com

Synageva: A Strong Candidate For Your Portfolio
10/8/2013 2:01:00 PM - Seeking Alpha

Alnylam Developing The Next Generation Drug Platform In The $19 Billion Cholesterol Market
10/8/2013 12:32:00 PM - Seeking Alpha

Pipeline Progress at Alnylam - Analyst Blog
10/3/2013 4:30:01 PM - Zacks.com

So You Have Some Questions About Tekmira Pharmaceuticals?
10/1/2013 11:15:00 AM - Seeking Alpha

Alnylam Up on Positive Phase I Data - Analyst Blog
9/24/2013 6:17:51 PM - Zacks.com

Amyloidosis Heats Up On Biotech M&A
9/18/2013 11:40:00 AM - Seeking Alpha

Orphan Drug Status for AEGR's Juxtapid in Japan - Analyst Blog
9/10/2013 11:57:58 AM - Zacks.com

Data Published on Alnylam's ATTR Candidates - Analyst Blog
8/29/2013 4:34:43 PM - Zacks.com

Alnylam Wins Orphan Drug Status - Analyst Blog
8/21/2013 3:20:01 PM - Zacks.com

Good News for Alnylam - Analyst Blog
8/19/2013 7:10:01 PM - Zacks.com

Narrower-than-Expected Q2 Loss at Alnylam - Analyst Blog
8/14/2013 9:35:01 AM - Zacks.com

Aegerion's Lojuxta Gets EU Approval - Analyst Blog
8/5/2013 5:20:01 PM - Zacks.com

Best Stocks: Isis, Gilead, Celgene, and Regeneron Take Over the Top Ranks
7/29/2013 9:20:00 AM - Minyanville

Alnylam Targets New Highs On Data Supporting RNAi
7/19/2013 6:14:00 PM - Seeking Alpha

Putting Alnylam's Positive ATTR Clinical Data In Context
7/19/2013 1:28:00 PM - Seeking Alpha

Market Wrap for Friday, July 12: Stocks Rise as S&P 500 Closes At New All-Time High
7/12/2013 4:45:17 PM - Benzinga

A Great Day And A Great Future For Alnylam
7/12/2013 11:45:00 AM - Seeking Alpha

Northera NDA Resubmitted By Chelsea - Analyst Blog
7/11/2013 6:56:18 PM - Zacks.com